Back to News & Events

Stony Brook Start-up Codagenix receives $322,000 to Fund Vaccine Research

Codagenix, a Stony Brook biotech company, has closed on $322,000 in public and private funding, including the latest investment from Accelerate Long Island and the Long Island Emerging Technologies Fund. Read more about the company and the funding from Accelerate Long Island and Newsday.com.

Related Stories

No related post found.